BioTheryX describes Protein Homeostatic Modulators with BTX-1188 showing notable antitumor activity July 10, 2020
Asieris cleared in China to begin global phase III trial of Cevira for high-grade cervical dysplasia July 9, 2020
Pivotal study of F-627 for chemotherapy-induced neutropenia meets primary and secondary endpoints July 8, 2020